We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Vice President of Quality Operations US Therapeutics confirms there is no established standard operting procedure to describe the periodic review, and the contents of the review, of deviations and investigations performed by the Quality Unit.